Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0084USD
−16.43 MUSD
304.96 MUSD
1.32 B
About VIVA BIOTECH HOLDINGS
Sector
Industry
CEO
Chen Mao
Website
Headquarters
Shanghai
Employees (FY)
2.08 K
Founded
2008
FIGI
BBG00Q8HRQN4
Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VBIZF is 0.0850 USD — it has increased by 31.82% in the past 24 hours. Watch Viva Biotech Holdings stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Viva Biotech Holdings stocks are traded under the ticker VBIZF.
VBIZF reached its all-time high on Feb 10, 2021 with the price of 1.8000 USD, and its all-time low was 0.0002 USD and was reached on Jan 20, 2021. View more price dynamics on VBIZF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VBIZF stock is 24.14% volatile and has beta coefficient of 2.19. Track Viva Biotech Holdings stock price on the chart and check out the list of the most volatile stocks — is Viva Biotech Holdings there?
Today Viva Biotech Holdings has the market capitalization of 145.31 M, it has increased by 4.93% over the last week.
Yes, you can track Viva Biotech Holdings financials in yearly and quarterly reports right on TradingView.
Viva Biotech Holdings is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
VBIZF net income for the last half-year is −16.20 M USD, while the previous report showed 146.15 K USD of net income which accounts for −11.18 K% change. Track more Viva Biotech Holdings financial stats to get the full picture.
As of Jun 30, 2024, the company has 2.08 K employees. See our rating of the largest employees — is Viva Biotech Holdings on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Viva Biotech Holdings EBITDA is 57.36 M USD, and current EBITDA margin is 18.74%. See more stats in Viva Biotech Holdings financial statements.
Like other stocks, VBIZF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Viva Biotech Holdings stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Viva Biotech Holdings technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Viva Biotech Holdings stock shows the sell signal. See more of Viva Biotech Holdings technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.